Diversified Healthcare Trust – (NASDAQ:DHCNI) Short Interest Down 61.5% in August

Diversified Healthcare Trust – (NASDAQ:DHCNI) was the target of a large drop in short interest in August. As of August 31st, there was short interest totaling 5,918 shares, a drop of 61.5% from the August 15th total of 15,391 shares. Based on an average daily trading volume, of 12,605 shares, the days-to-cover ratio is currently 0.5 days.

Diversified Healthcare Trust Trading Up 0.3%

Shares of DHCNI stock traded up $0.05 during trading hours on Tuesday, hitting $17.96. The stock had a trading volume of 8,736 shares, compared to its average volume of 52,561. Diversified Healthcare Trust has a one year low of $15.61 and a one year high of $19.09. The stock’s 50-day moving average price is $18.14 and its two-hundred day moving average price is $17.96.

Diversified Healthcare Trust Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, August 1st. Investors of record on Wednesday, July 15th were given a $0.3516 dividend. The ex-dividend date was Wednesday, July 15th. This represents a $1.41 annualized dividend and a yield of 7.8%.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.